Cargando…
Genetic and Hormonal Control of Bone Volume, Architecture, and Remodeling in XXY Mice
Klinefelter syndrome is the most common chromosomal aneuploidy in men (XXY karyotype, 1 in 600 live births) and results in testicular (infertility and androgen deficiency) and nontesticular (cognitive impairment and osteoporosis) deficits. The extent to which skeletal changes are due to testosterone...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Subscription Services, Inc., A Wiley Company
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153317/ https://www.ncbi.nlm.nih.gov/pubmed/20499350 http://dx.doi.org/10.1002/jbmr.104 |
_version_ | 1782209883825766400 |
---|---|
author | Liu, Peter Y Kalak, Robert Lue, YanHe Jia, Yue Erkkila, Krista Zhou, Hong Seibel, Markus J Wang, Christina Swerdloff, Ronald S Dunstan, Colin R |
author_facet | Liu, Peter Y Kalak, Robert Lue, YanHe Jia, Yue Erkkila, Krista Zhou, Hong Seibel, Markus J Wang, Christina Swerdloff, Ronald S Dunstan, Colin R |
author_sort | Liu, Peter Y |
collection | PubMed |
description | Klinefelter syndrome is the most common chromosomal aneuploidy in men (XXY karyotype, 1 in 600 live births) and results in testicular (infertility and androgen deficiency) and nontesticular (cognitive impairment and osteoporosis) deficits. The extent to which skeletal changes are due to testosterone deficiency or arise directly from gene overdosage cannot be determined easily in humans. To answer this, we generated XXY mice through a four-generation breeding scheme. Eight intact XXY and 9 XY littermate controls and 8 castrated XXY mice and 8 castrated XY littermate controls were euthanized at 1 year of age. Castration occurred 6 months prior to killing. A third group of 9 XXY and 11 XY littermates were castrated and simultaneously implanted with a 1-cm Silastic testosterone capsule 8 weeks prior to sacrifice. Tibias were harvested from all three groups and examined by micro–computed tomography and histomorphometry. Blood testosterone concentration was assayed by radioimmunoassay. Compared with intact XY controls, intact androgen-deficient XXY mice had lower bone volume (6.8% ± 1.2% versus8.8% ± 1.7%, mean ± SD, p = .01) and thinner trabeculae (50 ± 4 µm versus 57 ± 5 µm, p = .007). Trabecular separation (270 ± 20 µm versus 270 ± 20 µm) or osteoclast number relative to bone surface (2.4 ± 1.0/mm(2) versus 2.7 ± 1.5/mm(2)) did not differ significantly. Testosterone-replaced XXY mice continued to show lower bone volume (5.5% ± 2.4% versus 8.1% ± 3.5%, p = .026). They also exhibited greater trabecular separation (380 ± 69 µm versus 324 ± 62 µm, p = .040) but equivalent blood testosterone concentrations (6.3 ± 1.8 ng/mL versus 8.2 ± 4.2 ng/mL, p = .28) compared with testosterone-replaced XY littermates. In contrast, castration alone drastically decreased bone volume (p < .001), trabecular thickness (p = .05), and trabecular separation (p < .01) to such a great extent that differences between XXY and XY mice were undetectable. In conclusion, XXY mice replicate many features of human Klinefelter syndrome and therefore are a useful model for studying bone. Testosterone deficiency does not explain the bone phenotype because testosterone-replaced XXY mice show reduced bone volume despite similar blood testosterone levels. © 2010 American Society for Bone and Mineral Research. |
format | Online Article Text |
id | pubmed-3153317 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Wiley Subscription Services, Inc., A Wiley Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-31533172011-10-01 Genetic and Hormonal Control of Bone Volume, Architecture, and Remodeling in XXY Mice Liu, Peter Y Kalak, Robert Lue, YanHe Jia, Yue Erkkila, Krista Zhou, Hong Seibel, Markus J Wang, Christina Swerdloff, Ronald S Dunstan, Colin R J Bone Miner Res Original Article Klinefelter syndrome is the most common chromosomal aneuploidy in men (XXY karyotype, 1 in 600 live births) and results in testicular (infertility and androgen deficiency) and nontesticular (cognitive impairment and osteoporosis) deficits. The extent to which skeletal changes are due to testosterone deficiency or arise directly from gene overdosage cannot be determined easily in humans. To answer this, we generated XXY mice through a four-generation breeding scheme. Eight intact XXY and 9 XY littermate controls and 8 castrated XXY mice and 8 castrated XY littermate controls were euthanized at 1 year of age. Castration occurred 6 months prior to killing. A third group of 9 XXY and 11 XY littermates were castrated and simultaneously implanted with a 1-cm Silastic testosterone capsule 8 weeks prior to sacrifice. Tibias were harvested from all three groups and examined by micro–computed tomography and histomorphometry. Blood testosterone concentration was assayed by radioimmunoassay. Compared with intact XY controls, intact androgen-deficient XXY mice had lower bone volume (6.8% ± 1.2% versus8.8% ± 1.7%, mean ± SD, p = .01) and thinner trabeculae (50 ± 4 µm versus 57 ± 5 µm, p = .007). Trabecular separation (270 ± 20 µm versus 270 ± 20 µm) or osteoclast number relative to bone surface (2.4 ± 1.0/mm(2) versus 2.7 ± 1.5/mm(2)) did not differ significantly. Testosterone-replaced XXY mice continued to show lower bone volume (5.5% ± 2.4% versus 8.1% ± 3.5%, p = .026). They also exhibited greater trabecular separation (380 ± 69 µm versus 324 ± 62 µm, p = .040) but equivalent blood testosterone concentrations (6.3 ± 1.8 ng/mL versus 8.2 ± 4.2 ng/mL, p = .28) compared with testosterone-replaced XY littermates. In contrast, castration alone drastically decreased bone volume (p < .001), trabecular thickness (p = .05), and trabecular separation (p < .01) to such a great extent that differences between XXY and XY mice were undetectable. In conclusion, XXY mice replicate many features of human Klinefelter syndrome and therefore are a useful model for studying bone. Testosterone deficiency does not explain the bone phenotype because testosterone-replaced XXY mice show reduced bone volume despite similar blood testosterone levels. © 2010 American Society for Bone and Mineral Research. Wiley Subscription Services, Inc., A Wiley Company 2010-10 2010-04-07 /pmc/articles/PMC3153317/ /pubmed/20499350 http://dx.doi.org/10.1002/jbmr.104 Text en Copyright © 2010 American Society for Bone and Mineral Research http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. |
spellingShingle | Original Article Liu, Peter Y Kalak, Robert Lue, YanHe Jia, Yue Erkkila, Krista Zhou, Hong Seibel, Markus J Wang, Christina Swerdloff, Ronald S Dunstan, Colin R Genetic and Hormonal Control of Bone Volume, Architecture, and Remodeling in XXY Mice |
title | Genetic and Hormonal Control of Bone Volume, Architecture, and Remodeling in XXY Mice |
title_full | Genetic and Hormonal Control of Bone Volume, Architecture, and Remodeling in XXY Mice |
title_fullStr | Genetic and Hormonal Control of Bone Volume, Architecture, and Remodeling in XXY Mice |
title_full_unstemmed | Genetic and Hormonal Control of Bone Volume, Architecture, and Remodeling in XXY Mice |
title_short | Genetic and Hormonal Control of Bone Volume, Architecture, and Remodeling in XXY Mice |
title_sort | genetic and hormonal control of bone volume, architecture, and remodeling in xxy mice |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153317/ https://www.ncbi.nlm.nih.gov/pubmed/20499350 http://dx.doi.org/10.1002/jbmr.104 |
work_keys_str_mv | AT liupetery geneticandhormonalcontrolofbonevolumearchitectureandremodelinginxxymice AT kalakrobert geneticandhormonalcontrolofbonevolumearchitectureandremodelinginxxymice AT lueyanhe geneticandhormonalcontrolofbonevolumearchitectureandremodelinginxxymice AT jiayue geneticandhormonalcontrolofbonevolumearchitectureandremodelinginxxymice AT erkkilakrista geneticandhormonalcontrolofbonevolumearchitectureandremodelinginxxymice AT zhouhong geneticandhormonalcontrolofbonevolumearchitectureandremodelinginxxymice AT seibelmarkusj geneticandhormonalcontrolofbonevolumearchitectureandremodelinginxxymice AT wangchristina geneticandhormonalcontrolofbonevolumearchitectureandremodelinginxxymice AT swerdloffronalds geneticandhormonalcontrolofbonevolumearchitectureandremodelinginxxymice AT dunstancolinr geneticandhormonalcontrolofbonevolumearchitectureandremodelinginxxymice |